Answers are grounded in this paper and cite their sources.
This study aimed to synthesize and physicochemically characterize myrrh-mediated silver nanoparticles, evaluate their antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa, and assess their cytocompatibility with normal oral epithelial cells (OECs). Silver nanoparticles were synthesized using an aqueous Commiphora molmol myrrha extract and characterized using spectroscopic, diffraction, light-scattering, elemental, and electron-microscopic methods. Antibacterial activity was assessed using agar diffusion against Gram-positive and Gram-negative bacteria, with piperacillin/tazobactam as a control. Cytotoxicity in normal OECs, MCF-7 cells, and HeLa cells was assessed in vitro using tetrazolium reduction and neutral red uptake assays after 24 h. Nanoparticle formation was supported by a plasmon band at 416 nm and a face-centered cubic silver structure. Transmission electron microscopy showed predominantly spherical to quasi-spherical particles measuring 4.3–39.3 nm (mean, 17.7 nm); the hydrodynamic size distribution peaked at 210 nm, and the zeta potential was − 27.5 mV. The minimum inhibitory concentration was 10 µL for both bacteria; bactericidal endpoints were 40 and 70 µL for S. aureus and P. aeruginosa, respectively. OECs viability remained above 83% at 100 µg/mL, whereas MCF-7 and HeLa cells were 18.56% and 14.85, respectively. The preliminary results provide on the biocompatibility of myrrh-mediated silver nanoparticles in OECs and antibacterial activity against Gram-positive and Gram-negative bacteria. The study will be applied to odontogenic-related diseases.
No takes yet. Share an insight, caveat, or question.
Alkharji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: